High performance platform for drug discovery
ALiS enables high throughput screening of nanoparticle formulations and mRNA candidates in early-stage development.
This platform significantly accelerates discovery projects by performing numerous reactions – as much as 96 experiments in a day – collecting as little as 250 μl per sample and using automated washing cycles to avoid cross-contamination.
Controlled synthesis of lipid nanoparticles (LNPs)